Picture of Terrascend logo

TSND — Terrascend News Story

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapContrarian

Canada's TerrAscend Q2 revenue misses estimates, exits Michigan market

Overview

TerrAscend Q2 revenue misses analyst expectations, totaling $65 mln, per LSEG data

Company exits Michigan market to reduce debt and focus on core markets

Co completes $79 mln refinancing, secures additional $35 mln term loan for M&A

Outlook

TerrAscend plans to use $35 mln for strategic M&A

TerrAscend aims for improved profitability in New Jersey, Maryland, Pennsylvania

Company sees potential adult-use cannabis sales in Pennsylvania

Result Drivers

MICHIGAN EXIT - Co exits Michigan market to reduce debt and focus on core markets

NORTHEAST MARKETS - Strong performance in New Jersey, Maryland, and Pennsylvania drives results

PRICE COMPRESSION - Retail revenue increase offset by price compression in New Jersey

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 RevenueMiss$65 mln$67.90 mln (3 Analysts)
Q2 Gross Margin51.1%
Q2 Adjusted EBITDA from Cont. Ops$16 mln
Q2 Free Cash Flow$5 mln
Q2 Gross Profit$33.20 mln
Q2 Net Income from Cont. Ops-$6.40 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the drug retailers peer group is "buy" Wall Street's median 12-month price target for Terrascend Corp is C$1.88, about 64.8% above its August 6 closing price of C$0.66 Press Release: ID:nGNX3fn0KT (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Terrascend

See all news